APR 20, 2019 8:41 PM PDT

Underwater Forest May Bring New Therapeutics

WRITTEN BY: Nouran Amin

Microbes that produce defensive compounds have contributed to the major source of antibiotics and other therapeutics. However, due to the rise of antibiotic-resistant bacteria, researchers are now seeking new drug candidates offshore.

Currently, a family of sea-dwelling bacteria known as Actinobacteria have helped in producing new antibiotics with their rich source of bioactive microbial compounds. Now a study published in Frontiers in Microbiology, revealed that an underwater species of seaweed, called Laminaria ochroleuca, serves as a rich source of bacteria with antimicrobial and anticancer compounds--the discovery can lead to new therapeutics.

"About half of the 20,000+ microbe-derived drug candidates currently known come from Actinobacteria," says senior study author Dr. Maria de Fátima Carvalho of the Interdisciplinary Center of Marine and Environmental Research (CIIMAR), Portugal. "Now the supply of new species on land -- where they form spores and branched networks just like a fungus -- is beginning to run out. Several novel drug leads derived from marine Actinobacteria are already known. These include anticancer agent salinosporamide A, currently in clinical trials, and several new antibiotics that are effective against drug-resistant infections like MRSA and tuberculosis."

The study showed that extracts of the seaweed L. ochroleuca is a rich source of Actinobacteria with promising antimicrobial and anticancer activities.

"The brown alga Laminaria ochroleuca forms complex structures called kelp forests, which are among the most diverse and productive ecosystems in the world," says Carvalho. "But until now, no-one had characterized the Actinobacteria that live inside L. ochroleuca. Seven of the extracts inhibited growth of breast and particularly nerve cell cancers, while having no effect on non-cancer cells."

Kelp forests are among the most diverse and productive ecosystems in the world. Image: Shutterstock.

"We identified extracts from two Actinobacteria strains that do not match any known compounds in the most comprehensive international database of natural bioactive compounds. We intend to follow up on these exciting results."

Source: Frontiers

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 17, 2020
Chemistry & Physics
APR 17, 2020
Fish Tank Chemicals Aren't COVID-19 Medication, Says FDA
While the medical community is scrambling to find the proper medications for Sars-CoV-02 infection, a significant portio ...
APR 21, 2020
Drug Discovery & Development
APR 21, 2020
Researchers Develop COVID-19 Nasal Spray Vaccine
Researchers from the University of Waterloo in Canada are working on a DNA-based vaccine for COVID-19 that can be applie ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Only 3% of COVID-19 Antibody Tests Approved by FDA
So far, only 3% of at least 90 COVID-19 antibody tests in the US have been approved by the Food and Drug Administration ...
APR 25, 2020
Cannabis Sciences
APR 25, 2020
Researchers Trial Cannabis to Treat COVID-19
Researchers in Israel are investigating the potential for cannabis-derived products to treat patients with COVID-19. So ...
APR 22, 2020
Drug Discovery & Development
APR 22, 2020
Using Colors To Track The Spread of Drug Particles
Forensic scientists from the National Institute of Standards and Technology (NIST) are relying on color to see the sprea ...
MAY 02, 2020
Cancer
MAY 02, 2020
Tracking DNA Methylation as a Prognostic Marker
In the modern age of biological research, one of the tools that have become readily available in the ever-increasing dat ...
Loading Comments...